Novel Systemic Anticancer Therapy and Healthcare Utilization at the End of Life: A Retrospective Cohort Study

Novel Systemic Anticancer Therapy and Healthcare Utilization at the End of Life: A Retrospective Cohort Study

ABSTRACT Background Novel systemic anticancer therapies (SACT) in the form of targeted and immunotherapies are increasingly replacing traditional chemotherapy. Little is known about the impact of novel SACT on healthcare resource utilization (HCRU) at the end of life. Methodology A retrospective rev...

Full description

Saved in:
Bibliographic Details
Main Authors: Vikas Garg, Alejandra Ruiz Buenrostro, Katrina Heuniken, Rebecca Bagnarol, Mohamed Yousef, Katrina Sajewicz, Suman Dhanju, Kirsten Wentlandt, John Kuruvilla, Stephanie Lheureux, Camilla Zimmermann, Breffni Hannon
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:Cancer Medicine
Subjects:
end‐of‐life care
healthcare resource utilization
immunotherapy
systemic anticancer therapy
Online Access:https://doi.org/10.1002/cam4.70450
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/cam4.70450

Similar Items